Company & Sponsor Intelligence
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting1
Completed1
Countries1
Therapeutic footprint
adhdsubstance_use
Indexed studies
NCT06269627Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder
substance_use · United StatesPHASE4
substance_use · United StatesPHASE4
NCT02156089Neuroimaging, Omega-3 and Reward in Adults With ADHD (NORAA) Trial
adhd · United StatesPHASE2
adhd · United StatesPHASE2
NCT00000440Sertraline and Naltrexone for Alcohol Dependence
substance_use · United StatesPHASE2
substance_use · United StatesPHASE2
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →